🟢 Icecure Medical is trading 7.18% up in pre-market amid continued risk-on sentiment

Icecure Medical is trading 7.18% up at $2.09 alongside the broader September 21, 2026 equity rally.

• No new company-specific announcement was identified overnight.
• China regulatory approval for ProSense was announced September 10, 2026, and appears stale rather than a fresh catalyst.
• The move is most consistent with continued risk-on sentiment and after-hours momentum, though current index gains are modest.